Overview

Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
Lovastatin may protect against late effects of radiation therapy in patients with prostate cancer
Phase:
Phase 2
Details
Lead Sponsor:
Virginia Commonwealth University
Collaborator:
Hunter Holmes Mcguire Veteran Affairs Medical Center
Treatments:
Dihydromevinolin
L 647318
Lovastatin